First-time generic drug approval, August 2009
Generic drug approved by FDA (through August 2009): ethinyl estradiol/norgestimate tablets
Ethinyl estradiol/norgestimate tablets, 0.025/0.18 mg, 0.025/0.215 mg, and 0.025/0.25 mg (trade name, Tri-Lo Sprintec) (equiv to Ortho Tri-Cyclen Lo)
TEVA
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
